Hikma to funnel $267M to Ohio; Cingulate gets CRL for ADHD drug

June 4, 2026 11:42 AM EDT Manufacturing Hik­ma to fun­nel $267M to Ohio; Cin­gu­late gets CRL for AD­HD drug Anna Brown News Reporter Plus, news about West Phar­ma­ceu­ti­cal, Stal­ler­genes Greer and Curi­um: 🏭 Hik­ma’s US ex­pan­sion: The gener­ic drug­mak­er is in­vest­ing $267 mil­lion in … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER